Titagarh Rail shares zoom 9% on robust Q4, dividend payout
In the January-March quarter of FY24, the revenue of operations of Titagarh Rail stood at ₹1,o52.4 crore, up 8% as against ₹974.2 crore in the corresponding period of the previous year.
In the January-March quarter of FY24, the revenue of operations of Titagarh Rail stood at ₹1,o52.4 crore, up 8% as against ₹974.2 crore in the corresponding period of the previous year.
The company reported a 16.5% YoY jump in its consolidated net profit to ₹920.71 crore in the March quarter of FY24.
In the January to March quarter of FY24, Piramal Pharma’s revenue from operations grew 18% to ₹2,552 crore as against ₹2,164 crore in the corresponding period of the previous year.
The company managed to break even in the previous quarter and swung back to profitability in the March quarter of FY24.
The county’s fourth largest small finance bank is reportedly planning to apply for the universal bank license by May-June 2025.
The Tata Group company reported a multifold increase in consolidated net profit to ₹712 crore in the March quarter of FY24 as compared to ₹370.64 crore in the same period of FY23.
The company plans to merge Keimed, a promoter-owned wholesale pharma distribution business, with Apollo HealthCo over the next 24 to 30 months.
Analysts at brokerage firm Motilal Oswal gave a 'BUY' rating with a revised target price of ₹2,900 per share.
Despite beating analysts' estimates, in the March quarter of FY24, the company’s consolidated net profit declined by 8% to ₹2,385 crore, as against ₹3,074 crore in the corresponding period last year.
The company signed a definitive agreement with Dialog and Axiata Group to merge operations in Sri Lanka.